Vitro Release News Today

Helsinn publishes new data evaluating chlormethine gel's mode of action in Dermatology and Therapy Lugano, Switzerland, October 18, 2022 - Helsinn Group ("Helsinn"), a fully integrated, global

2School of Pharmaceutical Sciences, Jiangnan University, Wuxi, 214122, People’s Republic of China Correspondence: Fuxue Chen Tel/Fax +86-21-6613-5167 Purpose: Nanomaterial-based drug-delivery systems allowing for effective targeted delivery of smallmolecule chemodrugs to tumors have revolutionized cancer therapy. Recently, as novel nanomaterials with outstanding physicochemical properties, boron nitride nanospheres (BNs) have emerged as a promising candidate for drug delivery. However, poor d...